[Is it necessary to treat silent myocardial ischemia?].
At the present time there is no firm evidence that silent myocardial ischemia (on exercise or Holter ECG) should be treated with anti-ischemic drugs. Silent ischemic episodes obviously are a marker for ischemic activity of coronary artery disease and therefore a bad prognostic sign. However, antianginal drugs (nitrates, calcium-blockers, beta-blockers) have not been shown to improve prognosis. Patients with ischemic episodes should be further evaluated by thallium scintigraphy and coronary angiography. If a significant coronary disease is present, the established therapy with risk factor reduction, lipid lowering drugs and aspirin should be administered. In some instances PTCA or CABG may be indicated.
Klein
W
W
Kardiologischen Abteilung, Medizinischen Universitätsklinik Graz.
Eber
B
B
Fruhwald
F
F
D000787:Angina Pectoris / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage; D002423:Cause of Death; D001026:Coronary Artery Bypass; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology; D015716:Electrocardiography, Ambulatory / Q000187:drug effects; D006801:Humans; D017202:Myocardial Ischemia / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D011788:Quality of Life; D012307:Risk Factors
D001241:Aspirin
Ist die stumme Myokardischämie behandlungsbedürftig?